• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

极光激酶A/丝氨酸苏氨酸激酶15/乳腺癌肿瘤激活激酶增强膀胱癌细胞的染色体不稳定性。

Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.

作者信息

Fraizer Gail C, Diaz Miguel F, Lee I-Ling, Grossman H Barton, Sen Subrata

机构信息

Department of Biological Science, Kent State University, Kent, OH 44242, USA.

出版信息

Int J Oncol. 2004 Dec;25(6):1631-9.

PMID:15547700
Abstract

Chromosomal aneuploidy is associated with invasive bladder cancer and one of the genes implicated in these changes is Aurora-A/STK15/BTAK, that is localized on chromosome 20q13 and encodes a centrosome-associated serine/threonine kinase. To better understand the association between Aurora-A/STK15 expression, tumor aneuploidy and clinical prognosis, we sought to determine whether overexpression of Aurora-A/STK15 in cultured urothelial cells facilitated chromosomal instability. Using immunofluorescence staining, Northern and Western blot analyses, we verified that overexpression of Aurora-A/STK15 in bladder tumor cell lines enhanced chromosomal instability. Additionally, we observed that some bladder tumor cell lines expressed more Aurora-A/STK15 than cultured normal urothelial cells and that Aurora-A/STK15 expression was higher in an immortalized E7 urothelial cell line having 20q amplification than in an E6 line lacking 20q amplification. These results were consistent with our observations of higher mRNA levels in some T3 invasive bladder tumors than in T1 superficial tumors and adjacent normal bladder tissue. Overall our results suggest that overexpression of Aurora-A/STK15 in bladder tumor cells contributes to tumor progression by promoting chromosomal instability leading to aneuploidy.

摘要

染色体非整倍性与浸润性膀胱癌相关,参与这些变化的基因之一是Aurora-A/STK15/BTAK,它定位于20号染色体q13区域,编码一种与中心体相关的丝氨酸/苏氨酸激酶。为了更好地理解Aurora-A/STK15表达、肿瘤非整倍性与临床预后之间的关联,我们试图确定在培养的尿路上皮细胞中Aurora-A/STK15的过表达是否会促进染色体不稳定。通过免疫荧光染色、Northern印迹和Western印迹分析,我们证实膀胱肿瘤细胞系中Aurora-A/STK15的过表达增强了染色体不稳定。此外,我们观察到一些膀胱肿瘤细胞系表达的Aurora-A/STK15比培养的正常尿路上皮细胞更多,并且在具有20号染色体扩增的永生化E7尿路上皮细胞系中Aurora-A/STK15的表达高于缺乏20号染色体扩增的E6细胞系。这些结果与我们在一些T3期浸润性膀胱肿瘤中观察到的mRNA水平高于T1期浅表肿瘤和相邻正常膀胱组织的结果一致。总体而言,我们的结果表明膀胱肿瘤细胞中Aurora-A/STK15的过表达通过促进染色体不稳定导致非整倍性,从而促进肿瘤进展。

相似文献

1
Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells.极光激酶A/丝氨酸苏氨酸激酶15/乳腺癌肿瘤激活激酶增强膀胱癌细胞的染色体不稳定性。
Int J Oncol. 2004 Dec;25(6):1631-9.
2
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.肿瘤扩增激酶STK15/BTAK可诱导中心体扩增、非整倍体及细胞转化。
Nat Genet. 1998 Oct;20(2):189-93. doi: 10.1038/2496.
3
The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.极光激酶A/Aurora-A/丝氨酸/苏氨酸蛋白激酶15/STK15/BTAK在人食管鳞状细胞癌中的表达的临床意义
Clin Cancer Res. 2005 Mar 1;11(5):1827-34. doi: 10.1158/1078-0432.CCR-04-1627.
4
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.致癌性丝氨酸/苏氨酸激酶15/膀胱癌激活激酶/极光激酶A在人类胰腺癌中的过表达
Clin Cancer Res. 2003 Mar;9(3):991-7.
5
Amplification/overexpression of a mitotic kinase gene in human bladder cancer.人类膀胱癌中一种有丝分裂激酶基因的扩增/过表达
J Natl Cancer Inst. 2002 Sep 4;94(17):1320-9. doi: 10.1093/jnci/94.17.1320.
6
Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.在源自人类卵巢癌的致瘤性细胞培养物中,STK15/Aurora - A/BTAK频繁过表达且存在染色体不稳定现象。
Oncol Res. 2005;15(1):49-57. doi: 10.3727/096504005775082101.
7
Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer.中心体、染色体乘客蛋白及细胞周期相关的信使核糖核酸在散发性结直肠癌的发展过程中受到不同程度的调控。
J Pathol. 2006 Mar;208(4):462-72. doi: 10.1002/path.1914.
8
Simultaneous Aurora-A/STK15 overexpression and centrosome amplification induce chromosomal instability in tumour cells with a MIN phenotype.极光激酶A/丝氨酸苏氨酸激酶15(Aurora-A/STK15)同时过表达和中心体扩增会在具有微卫星不稳定性(MIN)表型的肿瘤细胞中诱导染色体不稳定。
BMC Cancer. 2007 Nov 13;7:212. doi: 10.1186/1471-2407-7-212.
9
Low level STK15 amplification in histologically benign urothelium of patients with bladder cancer adversely predicts patient outcome following cystectomy.膀胱癌患者组织学良性尿路上皮中低水平的STK15扩增对膀胱切除术后患者的预后有不良预测作用。
Int J Oncol. 2007 Oct;31(4):793-802.
10
Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast.极光激酶A/丝氨酸苏氨酸激酶15/乳腺癌扩增激酶(Aurora A/STK15/BTAK)过表达的缺失与乳腺原位癌向浸润性导管癌的转变相关。
Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1518-22.

引用本文的文献

1
Knowledge mapping of AURKA in Oncology:An advanced Bibliometric analysis (1998-2023).肿瘤学中极光激酶A(AURKA)的知识图谱:一项高级文献计量分析(1998 - 2023年)
Heliyon. 2024 May 30;10(11):e31945. doi: 10.1016/j.heliyon.2024.e31945. eCollection 2024 Jun 15.
2
eEF1A2 promotes PTEN-GSK3β-SCF complex-dependent degradation of Aurora kinase A and is inactivated in breast cancer.eEF1A2 促进 PTEN-GSK3β-SCF 复合物依赖性降解 Aurora 激酶 A,并在乳腺癌中失活。
Sci Signal. 2024 Mar 5;17(826):eadh4475. doi: 10.1126/scisignal.adh4475.
3
Molecular Markers of Anticancer Drug Resistance in Head and Neck Squamous Cell Carcinoma: A Literature Review.
头颈部鳞状细胞癌中抗癌药物耐药性的分子标志物:文献综述
Cancers (Basel). 2018 Oct 10;10(10):376. doi: 10.3390/cancers10100376.
4
Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia.复发性儿童B淋巴细胞急性白血病基因表达的荟萃分析
BMC Cancer. 2017 Feb 10;17(1):120. doi: 10.1186/s12885-017-3103-1.
5
Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.AURKA 基因(rs2273535 和 rs1047972)多态性与乳腺癌风险的关联:一项涉及 37221 例受试者的荟萃分析。
Cancer Cell Int. 2014 Sep 5;14(1):91. doi: 10.1186/s12935-014-0091-y. eCollection 2014.
6
The response of head and neck squamous cell carcinoma to cetuximab treatment depends on Aurora kinase A polymorphism.头颈部鳞状细胞癌对西妥昔单抗治疗的反应取决于极光激酶A多态性。
Oncotarget. 2014 Jul 30;5(14):5428-38. doi: 10.18632/oncotarget.2117.
7
Aurora A orchestrates entosis by regulating a dynamic MCAK-TIP150 interaction.极光激酶A通过调节动力蛋白MCAK与TIP150之间的动态相互作用来调控细胞自噬。
J Mol Cell Biol. 2014 Jun;6(3):240-54. doi: 10.1093/jmcb/mju016. Epub 2014 May 20.
8
Aurora A Kinase as a diagnostic urinary marker for urothelial bladder cancer.极光激酶A作为尿路上皮膀胱癌的诊断性尿液标志物。
World J Urol. 2015 Jan;33(1):105-10. doi: 10.1007/s00345-014-1267-8. Epub 2014 Feb 23.
9
Mitosis as an anti-cancer drug target.有丝分裂作为一种抗癌药物靶点。
Chromosoma. 2013 Oct;122(5):431-49. doi: 10.1007/s00412-013-0419-8. Epub 2013 Jun 18.
10
Aneuploidy, oncogene amplification and epithelial to mesenchymal transition define spontaneous transformation of murine epithelial cells.非整倍体、癌基因扩增和上皮-间充质转化定义了小鼠上皮细胞的自发转化。
Carcinogenesis. 2013 Aug;34(8):1929-39. doi: 10.1093/carcin/bgt138. Epub 2013 Apr 25.